Medicinal product name Pramipexole ELVIM 0.7 mg tablets
Pharmaceutical form Tablet
Strength 0.7 mg 
Information from the MAH on shortages No information on expected shortages
Availability of medicinal product
Product No.Package sizeWholesalers' stock state
09-0165-01 KZSRN30 Is available
Legal status Rx Prescription (Pr.)
KZSR Reimbursed medicines reference product
Package leaflet MS Word document 18-06-2020
Summary of product characteristics MS Word document 18-06-2020
ATC code N04BC05 Anti-parkinson drugs

Important notice

Additional information regarding the use for persons aged 75+

If used as "ANTI-PARKINSON DRUGS"
SubstanceClassComment
PramipexolumCSuitable for older persons, with specific cautions. Sedative. Start therapy under specialist supervision. Reduce the dose in even moderate renal insufficiency. The most common adverse effects are orthostatic hypotension, gastrointestinal symptoms, drowsiness, hallucinations, confusion and sudden bouts of falling asleep. Take interactions into account, especially with antipsychotics.

Medicinal products (3)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Is available (according to the information provided by wholesalers)
(1798 containers)
Tamro, Recipe Plus, Magnum Medical, ELVIM, Euroaptieka, Jelgavfarm N30
(0,7 mg)
PA/Al/PVC/Al blister 8.41 
KZSR*
09-0165-01 Labelling text Labelling text Mar 9, 2017
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N100
(0,7 mg)
PA/Al/PVC/Al blister    09-0165-02 Labelling text Labelling text Mar 9, 2017
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N10
(0,7 mg)
PA/Al/PVC/Al blister    09-0165-03 Labelling text Labelling text Mar 9, 2017
* Indication about medicine on the List of state reimbursed medicines is just informative. Source of the information is the National Health Service. For details please visit the NHS website.

Registration information

Marketing authorisation No. 09-0165
Date of authorisation Apr 30, 2009
MA valid until For unlimited time
Marketing authorisation holder, country Elvim, SIA, Latvia